22 February 2022

Mia Rosenblatt, Associate Director of Policy, Evidence and Influencing at Breast Cancer Now, said:

“We’re deeply disappointed that the government’s announcement yesterday fell short on its promise to protect those who are at greatest risk from COVID-19, including people with breast cancer who are using immunosuppressant therapies.

“The needs of vulnerable people must be accounted for every time COVID-19 guidance gets updated, as a critical part of ensuring appropriate support and safeguards are in place. The end of free testing after 1st April and removing the legal requirements to self-isolate following a positive test will be concerning for many people living with breast cancer and further clarity is urgently needed on whether those most at risk of COVID-19 will be able to access free testing.

“We share NHS Confederation’s concerns about NHS staff being excluded from free symptomatic testing – which helps keep the NHS a COVID-safe environment for both staff and patients.

“We’re calling on the government to swiftly respond to our concerns, and those raised by others across the charity and healthcare sectors, so that those to whom COVID-19 poses the greatest risk can feel reassured that necessary measures are in place to keep them safe as restrictions are eased.

“Anyone seeking information and support can speak to our expert nurses by calling our free Helpline on 0808 800 6000.”

- ENDS -